2 months ago

GSK to buy US cancer treatment firm Nuvalent for $10.6bn

The Guardian
2 months ago

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

FT
Tags: US cancer treatment firm Nuvalent, cancer biotech Nuvalent, GSK, talks,

←Top Latest Headlines

Get it on Google Play

Help Keep This Site Alive
I built and maintain this site on my own, but rising hosting costs are becoming unsustainable. Your donation would help cover costs and allow me to focus on improving the site.